GMO Financial Gate, Inc. (4051) AI Stock Analysis

• Market Cap: ¥43.87B
• Dividend Yield: 1.88%
• Average Volume (3M): 48.15K
• Price to Earnings (P/E): 26.1
• Beta (1Y): 0.96
• Revenue Growth: -4.16%
• EPS Growth: 66.20%
• Country: JP
• Employees: 123
• Sector: Technology
• Sector Strength: 88
• Industry: Business Equipment & Supplies
• EPS (TTM): 78.11
• Shares Outstanding: 8,339,480
• 10 Day Avg. Volume: 38,560
• 30 Day Avg. Volume: 48,146
• PEG Ratio: 0.50
• Price to Book (P/B): 8.14
• Price to Sales (P/S): 2.84
• P/FCF Ratio: 46.37
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 229.07
• Revenue Forecast (FY): ¥20.41B

• Rating: 64 Neutral
• Price Target: ¥5,500.00 ▼(-7.25% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is primarily supported by strong profitability and improving margins, plus a generally sound balance sheet. It is held back by sharp TTM cash-flow deterioration and a TTM debt increase, while technicals are mixed (below longer-term moving averages) and valuation is not particularly cheap given the P/E and modest yield.

Positive Factors

Margin Expansion & Profitability

Sustained margin expansion to ~35% gross and ~9% net reflects improved pricing, cost control and operating leverage. That higher structural profitability increases free cash potential and resilience to revenue cycles, supporting durable earnings power and reinvestment capacity.

High Return on Equity

ROE near the high-20s indicates management extracts strong returns from equity capital, signalling disciplined capital allocation. Persistently high ROE supports shareholder value creation, funds growth internally and implies competitive advantages in margin or asset efficiency.

Moderate Leverage / Healthy Balance Sheet

A debt-to-equity around 0.32 denotes conservative leverage that preserves financial flexibility. That structural cushion allows targeted investments or weathering cyclical weakness without forcing asset sales, supporting longer-term strategic execution and credit stability.

Negative Factors

TTM Cash-Flow Deterioration

Sharp TTM declines in operating and free cash flow weaken the firm's ability to fund capex, pay down debt, or return capital. If persistent, poor cash conversion can force external financing, elevate cost of capital and undermine the benefit of strong reported margins.

Increase in Total Debt (TTM)

A recent rise in total debt while cash generation weakens raises refinancing and servicing risk. Elevated leverage during periods of uneven cash flow narrows strategic options, could increase interest burden, and makes the company more sensitive to revenue or margin setbacks.

Revenue Volatility / Recent Growth Swing

An abrupt swing to flat/negative annual revenue after prior growth signals instability in demand or execution. Revenue volatility undermines predictability of earnings and cash conversion, complicates planning and increases the risk that margin gains may prove cyclical.

GMO Financial Gate, Inc. Business Overview & Revenue Model

Company Description

GMO Financial Gate, Inc. (4051) is a leading financial technology company that specializes in providing a range of digital finance solutions. Operating primarily in the fintech sector, the company offers services including payment processing, online banking, and investment management. With a focus on enhancing user experience through innovative technology, GMO Financial Gate aims to streamline financial transactions and empower consumers and businesses with accessible financial tools.

How the Company Makes Money

GMO Financial Gate, Inc. generates revenue through multiple streams, including transaction fees from payment processing services, subscription fees for premium banking services, and commissions from investment products. The company partners with various merchants and financial institutions to facilitate seamless payment solutions, which contributes to its earnings. Additionally, strategic alliances with technology providers enhance its service offerings, enabling the company to tap into new markets and customer bases, thereby boosting its overall revenue.

GMO Financial Gate, Inc. Financial Statement Overview

Summary

Strong income-statement performance with improved scale and margin expansion, and a generally healthy balance sheet with strong ROE. However, cash flow is the key weakness: TTM operating and free cash flow deteriorated sharply and debt stepped up in TTM, increasing reliance on consistent cash conversion.

Income Statement

Profitability and scale have improved materially over the last several years. Revenue rose strongly from 2021 to 2024, and while 2025 annual revenue was roughly flat, TTM (Trailing-Twelve-Months) shows a sharp re-acceleration. Margins expanded meaningfully versus earlier years (gross margin ~35% and net margin ~9% in 2025 vs. ~25%/~5% in 2023), with EBIT and EBITDA margins also higher—signaling better operating leverage. The main watch-out is the abrupt swing in 2025 annual growth to slightly negative, which raises the risk that recent momentum may be more volatile than the long-term trend suggests.

Balance Sheet

The balance sheet looks healthy overall with moderate leverage and improving returns. Debt-to-equity is around ~0.32 in the latest periods, which is manageable, and equity has generally grown over time. Return on equity is strong (about ~26% in 2025 annual and ~28% in TTM (Trailing-Twelve-Months)), indicating efficient capital use. The key concern is the step-up in total debt in TTM (Trailing-Twelve-Months) versus the 2025 annual figure, which reduces flexibility if cash generation weakens.

Cash Flow

Cash generation is the weakest area. While 2025 annual operating cash flow and free cash flow were solid and free cash flow was largely supported relative to net income, TTM (Trailing-Twelve-Months) shows a sharp deterioration in both operating cash flow and free cash flow, with free cash flow down heavily year over year. Historically, cash flow has been uneven (including negative operating/free cash flow in 2022), which suggests working-capital or investment swings can meaningfully impact liquidity despite strong reported earnings.

Breakdown	TTM	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Income Statement
Total Revenue	18.29B	17.93B	18.71B	15.91B	10.30B	7.09B
Gross Profit	6.49B	6.27B	6.05B	3.91B	2.77B	2.02B
EBITDA	2.96B	2.87B	2.06B	1.52B	1.11B	893.28M
Net Income	1.67B	1.63B	1.01B	746.43M	472.52M	411.38M
Balance Sheet
Total Assets	16.19B	13.83B	14.21B	9.26B	6.64B	7.14B
Cash, Cash Equivalents and Short-Term Investments	4.98B	4.27B	5.07B	4.02B	2.52B	3.43B
Total Debt	5.00B	2.00B	2.00B	1.50B	646.00K	6.94M
Total Liabilities	9.86B	7.34B	8.32B	4.15B	1.97B	2.76B
Stockholders Equity	6.09B	6.26B	5.63B	4.91B	4.50B	4.22B
Cash Flow
Free Cash Flow	248.66M	1.10B	1.14B	366.07M	-719.20M	488.44M
Operating Cash Flow	376.45M	1.23B	1.71B	865.91M	-212.18M	957.08M
Investing Cash Flow	-1.09B	-898.86M	-719.17M	-529.93M	-531.21M	-465.67M
Financing Cash Flow	2.05B	-1.13B	63.81M	1.28B	-303.04M	-3.81M

GMO Financial Gate, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5930.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4051, the sentiment is Positive. The current price of 5930 is above the 20-day moving average (MA) of 5151.00, above the 50-day MA of 5123.60, and above the 200-day MA of 5397.15, indicating a neutral trend. The MACD of 13.90 indicates Negative momentum. The RSI at 57.51 is Neutral, neither overbought nor oversold. The STOCH value of 78.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4051.

GMO Financial Gate, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6418	78 Outperform	¥36.91B	7.27	―	4.54%	-20.75%	7.75%
6448	76 Outperform	¥821.96B	14.54	7.77%	3.16%	4.30%	78.29%
8060	73 Outperform	¥766.93B	18.36	10.63%	2.03%	5.40%	23.70%
7752	71 Outperform	¥828.03B	12.93	5.91%	2.78%	4.46%	70.22%
4051	64 Neutral	¥43.87B	26.09	―	1.88%	-4.16%	66.20%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
4902	47 Neutral	$289.19B	-22.96	-12.69%	0.71%	-11.22%	-731.07%

GMO Financial Gate, Inc. Corporate Events

GMO Financial Gate Secures ¥3 Billion Refinancing to Support Liquidity and Terminal Purchases

GMO Financial Gate, Inc. has arranged a new round of borrowing under existing overdraft agreements to refinance loan funds maturing on February 27, 2026. The company will borrow a total of JPY 3 billion from Sumitomo Mitsui Banking Corporation, Mizuho Bank, Ltd. and MUFG Bank, Ltd., with each lender providing JPY 1 billion on a six-month, floating-rate basis, repayable in a lump sum at maturity.

The refinancing is intended to secure on-hand liquidity for working capital needs, particularly for payment terminal purchases, and to maintain and strengthen the stability of the company’s financial base. GMO Financial Gate expects the impact of this borrowing on its consolidated financial results for the fiscal year ending September 30, 2026, to be immaterial, signaling that the transaction is primarily a balance-sheet and liquidity management measure rather than a driver of earnings performance.

The most recent analyst rating on (JP:4051) stock is a Hold with a Yen5030.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.

GMO Financial Gate Beats Q1 Profit Guidance, Sharpens Merchant-Focused Payments Strategy

GMO Financial Gate reported first-quarter fiscal 2026 operating profit ahead of internal guidance, indicating stronger-than-expected performance early in the fiscal year. Management emphasized a strategy of delivering not only payment platforms but also additional solutions for merchants, aiming to drive continued growth by deepening its role in clients’ payment ecosystems and reinforcing its competitive position in the fintech payments market.

The most recent analyst rating on (JP:4051) stock is a Hold with a Yen5030.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.

GMO Financial Gate Launches Bitcoin-Based Shareholder Benefit Program

GMO Financial Gate, Inc. has resolved to introduce a shareholder benefit program aimed at encouraging long-term shareholding and deepening investor understanding of its own and the broader GMO Internet Group’s businesses. The program underscores the company’s intention to enhance sustainable corporate value and strengthen its relationship with shareholders.

Starting with shareholders of record as of March 31, 2026, eligible investors holding at least 100 shares for a continuous six months will receive Bitcoin credits based on their GMO Financial Gate share purchases executed through GMO CLICK Securities, Inc. The benefit, capped at JPY 10,000 and distributed via GMO Coin crypto accounts, also promotes use of group-affiliated platforms, potentially reinforcing GMO’s ecosystem in both securities trading and digital assets.

The most recent analyst rating on (JP:4051) stock is a Hold with a Yen5030.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.

GMO Financial Gate Lifts Q1 Profit and Hikes Full-Year Dividend Forecast

GMO Financial Gate reported first-quarter FY2026 consolidated revenue of ¥4,942 million, up 7.8% year on year, with operating profit rising 15.3% to ¥954 million and profit attributable to owners of parent up 7.0% to ¥644 million. Despite higher earnings per share and solid profit growth, the equity ratio declined to 37.6% from 45.2% as total assets expanded, while the company maintained its dividend stance of no interim payouts and forecast a full-year dividend of ¥125 per share alongside a 10.1% rise in full-year revenue and a 25.5% increase in operating profit, signaling confidence in continued business expansion.

For the second quarter and full fiscal year ending September 2026, GMO Financial Gate projects cumulative Q2 revenue of ¥8,639 million, slightly below the prior period, with broadly flat operating profit and a forecast decline in interim profit, but expects full-year profit attributable to owners of parent to climb 14.6% to ¥1,870 million. The stable accounting policies, unchanged subsidiary structure, and rising full-year earnings outlook indicate operational stability and a strategy of returning growing profits to shareholders through an increased year-end dividend despite near-term margin pressures.

The most recent analyst rating on (JP:4051) stock is a Hold with a Yen5030.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.

GMO Financial Gate Details Relationship with Controlling Shareholders

GMO Financial Gate, Inc. announced its relationship with its controlling shareholders, GMO Internet Group, Inc. and GMO Payment Gateway, Inc., which hold significant voting rights and influence over the company. The company emphasizes its strategic position within the group, focusing on face-to-face payment solutions, while ensuring that transactions with parent companies protect minority shareholders’ interests through careful examination and independent oversight.

The most recent analyst rating on (JP:4051) stock is a Hold with a Yen6456.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.

GMO Financial Gate Secures JPY 3 Billion in Overdraft Agreements

GMO Financial Gate, Inc. announced its decision to borrow funds under overdraft agreements totaling JPY 3 billion from major banks to secure liquidity and strengthen its financial base. This move is aimed at preparing for future working capital needs, particularly for terminal purchases, and is expected to have an immaterial impact on the company’s financial results for the fiscal year ending September 30, 2026.

The most recent analyst rating on (JP:4051) stock is a Hold with a Yen6456.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.